on SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma Listed on MDAX for the First Time
SCHOTT Pharma AG & Co. KGaA, a leader in drug containment and delivery systems, will join the MDAX index on September 23, 2024. The company's shares will be among the 90 most significant on the Frankfurt Stock Exchange. The MDAX includes the 50 largest companies following the DAX in market capitalization.
CEO Andreas Reisse expressed delight at the promotion, highlighting the confidence of investors in the company. SCHOTT Pharma has been traded on the Frankfurt Stock Exchange since September 2023 and on the SDAX since December 2023. CFO Dr. Almuth Steinkühler sees this as a key step in strengthening market visibility and achieving growth targets.
The company reported its Q3 2024 results on August 29, 2024, and will release its annual report on December 12, 2024.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SCHOTT Pharma AG & Co. KGaA news